We also do not know the seroconversion rate for mild or asymptomatic cases (every study measuring this seems to use an entirely-hospitalized or mostly-hospitali

We also do not know the seroconversion rate for mild or asymptomatic cases (every study measuring this seems to use an entirely-hospitalized or mostly-hospitalized cohort). EDIT: Hey hey it looks like some information is finally coming out, and what do you know, it supports the idea that milder cases don't develop IgG antibodies as often: https://www.biorxiv.org/content/10.1101/2020.05.21.108308v1 https://www.biorxiv.org/content/10.1101/2020.05.21.108308v1